Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Russia to begin Phase III trials of second COVID-19 vaccine in Nov-Dec: TASS

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration

Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday.

Early-stage clinical trials for the vaccine were completed on Wednesday.

(Writing by Alexander Marrow; Editing by Polina Ivanova)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.